List view / Grid view

Novartis

DNA strand with cross hares over it - idea of targeting genes for gene therapy

SMA drug Zolgensma^® has “significant therapeutic benefit”, according to interim data

5 October 2020 | By Hannah Balfour (European Pharmaceutical Review)

Treatment with Zolgensma® (onasemnogene abeparvovec) resulted in rapid and sustained improvement in motor function in spinal muscular atrophy (SMA) patients.

Two pharma manufacturing plant workers surrounded by equipment

article

A glimpse at how Novartis’ manufacturing and supply organisation responded to COVID-19

28 August 2020 | By Steffen Lang (Novartis)

The rapid evolution of the COVID-19 situation has created significant barriers to normal operations, from locking down borders to the imposition of restrictions on trade and export – not to mention a surge in demand for many common medicines. Each of these events in isolation can affect production and supply,…

article

How digitalisation can help pharma weather the COVID-19 storm

28 August 2020 | By Andrew Dunbar (Appnovation)

Andrew Dunbar outlines five digital technologies that can help pharma function to the best of its abilities over the course of the COVID-19 pandemic.

news

European Commission approves Novartis’ Xolair^® (omalizumab)

7 August 2020 | By Victoria Rees (European Pharmaceutical Review)

Novartis' Xolair (omalizumab) has been approved by the European Commission as an add-on therapy with intranasal corticosteroids to treat severe chronic rhinosinusitis with nasal polyps.

article

Top 10 biopharma workplaces in the US

29 July 2020 | By Victoria Rees (European Pharmaceutical Review)

A Fortune report reveals the best 10 places to work in the US biopharmaceutical industry.

news

Sandoz and Austrian government to invest in European antibiotic manufacturing

27 July 2020 | By Victoria Rees (European Pharmaceutical Review)

Sandoz plans to invest €150 million and the Austrian government €50 million into integrated antibiotic manufacturing operations at Kundl.

news

Novartis launches not-for-profit COVID-19 medications portfolio

17 July 2020 | By Hannah Balfour (European Pharmaceutical Review)

The portfolio will be offered to low- and lower-middle-income countries to help financially strained healthcare systems care for COVID-19 patients.

Patient with multiple sclerosis - siponimod treatment

news

NICE does not recommend Novartis’ siponimod for secondary progressive MS

29 June 2020 | By Victoria Rees (European Pharmaceutical Review)

NICE has decided to not recommend Mayzent (siponimod) for use on the NHS as a secondary progressive multiple sclerosis treatment because its clinical trial did not directly compare it to interferon beta-1b.

boardroom with huge table surrounded by a diverse group of people

article

Radical innovation occurs when pharma looks outside its own world

18 June 2020 | By Stephen Frost (Frost Included)

Pharma executives are committed to bringing drugs to market to improve the lives of patients but is the industry too introspective to be truly innovative?

article

COVID-19: the big repurpose and even bigger pharmaceutical partnership

14 May 2020 | By Heidi West (Vohra Wound Physicians)

Heidi West discusses how academia, government and the pharmaceutical industry can work together to potentially repurpose drugs for the treatment of COVID-19.

news

FDA approves Tabrecta for treatment of metastatic non-small cell lung cancer

11 May 2020 | By Victoria Rees (European Pharmaceutical Review)

The FDA has approved Tabrecta (capmatinib) for patients with metastatic non-small cell lung cancer whose tumours have a mutation that leads to MET exon 14 skipping.

news

Collaboration to develop automated platform for environmental monitoring

14 April 2020 | By Victoria Rees (European Pharmaceutical Review)

An Irish partnership between academia and industry aims to develop a robotic method for automated environmental monitoring in bioprocessing.

news

Study suggests Zolgensma will generate $2.5bn of global sales by 2025

31 March 2020 | By Victoria Rees (European Pharmaceutical Review)

According to researchers, Zolgensma, made by Novartis, will lead the global spinal muscular atrophy market and generate billions in sales.

news

FDA approves Isturisa (osilodrostat) treatment for Cushing’s disease

9 March 2020 | By Hannah Balfour (European Pharmaceutical Review)

The FDA has approved Isturisa for Cushing’s disease treatment after it demonstrated significant efficacy in clinical trials.

news

FDA and EMA accept licence applications for multiple sclerosis treatment

27 February 2020 | By Rachael Harper (European Pharmaceutical Review)

The FDA and EMA have accepted licence applications for ofatumumab, a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS).

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Novartis